(Q40774158)

English

Two novel cucurbitacins, neocucurbitacins A and B, from the Brazilian folk medicine "Buchinha" (Luffa operculata) and their effect on PEBP2alphaA and OCIF gene expression in a human osteoblast-like Saos-2 cell line

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Two novel cucurbitacins, neocucurbitacins A and B, from the Brazilian folk medicine "Buchinha" (Luffa operculata) and their effect on PEBP2alphaA and OCIF gene expression in a human osteoblast-like Saos-2 cell line (English)

1 reference

Europe PubMed Central

23 September 2017

Luffa operculata

1 reference

0 references

(9beta,23E)-25-Acetyloxy-16alpha,20-dihydroxy-9-methyl-19-nor-2-oxalanosta-1(10),5,23-triene-3,11,22-trione

1 reference

[6-Hydroxy-6-(2-hydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1,2,3,3b,4,11-hexahydroindeno[4,5-h]isochromen-1-yl)-2-methyl-5-oxohept-3-en-2-yl] acetate

1 reference

1 reference

14-[(4E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-13-hydroxy-1,6,6,11,15-pentamethyl-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2,7-diene-5,17-dione

1 reference

Isocucurbitacin B

1 reference

(8S,9R,10S,13R,14S)-17-[(2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione

1 reference

1 reference

(9beta,23E)-16alpha,20,25-Trihydroxy-9-methyl-19-nor-2-oxalanosta-1(10),5,23-triene-3,11,22-trione

1 reference

1-(2,6-Dihydroxy-6-methyl-3-oxohept-4-en-2-yl)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-1,2,3,3b,4,11-hexahydroindeno[4,5-h]isochromene-7,10-dione

1 reference

1 reference

author name string

Kawahara N

1

1 reference

Europe PubMed Central

23 September 2017

Kurata A

2

1 reference

Europe PubMed Central

23 September 2017

Hakamatsuka T

3

1 reference

Europe PubMed Central

23 September 2017

Sekita S

4

1 reference

Europe PubMed Central

23 September 2017

Satake M

5

1 reference

Europe PubMed Central

23 September 2017

language of work or name

1 reference

Chemical & Pharmaceutical Bulletin

publication date

2001

1 reference

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb/49/10/49_10_1377/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.49.1377?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

Europe PubMed Central

23 September 2017

49

1 reference

Europe PubMed Central

23 September 2017

10

1 reference

Europe PubMed Central

23 September 2017

1377-1379

1 reference

Europe PubMed Central

23 September 2017

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.49.1377?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Tumor Inhibitors. XXIII.(1) The Cytotoxic Principles of Marah oreganus H.(2)

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

New cucurbitacins from Phormium tenax and Marah oreganus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Screening for bioactive compounds targeting the cellular signal transduction pathway using an RT-PCR-based bioassay system

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.49.1377

Identifiers

10.1248/CPB.49.1377

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40774158&oldid=2131104025"